Video
Experts break down latest CAR T-cell advances in lymphoma
ORLANDO – An expert panel of physicians discusses the latest research on CAR T-cell therapy in lymphoma, presented at the 2019 annual meeting of...
News
Hematology News welcomes Dr. Ify Osunkwo as editor in chief
Dr. Osunkwo is a specialist in sickle cell disease and the director of the sickle cell program at Levine Cancer Institute in Charlotte, N.C.
News
Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematology
ORLANDO – The list, which was released by ASH and the American Society of Pediatric Hematology/Oncology, includes five unnecessary tests or...
News
Myeloma patients over age 70 can benefit from auto-HC transplant
ORLANDO – Researchers said all myeloma patients should be referred a transplant center, regardless of age.
News
FDA approves treatment for sickle cell pain crises
Crizanlizumab-tmca (Adakveo) is approved for patients with sickle cell disease who are aged 16 years and older.
News
FDA approves anemia treatment for transfusion-dependent beta thalassemia patients
Luspatercept-aamt (Reblozyl) is approved for adults with beta thalassemia who require regular red blood cell transfusions.
News
ASCO to award $50,000 young investigator grant to study MCL
The award is a 1-year grant of $50,000 to pursue clinical research on mantle cell lymphoma.
News
Hematopoietic cell transplant offers realistic cure in secondary AML
The observational trial showed that survival was significantly higher with transplant than with chemotherapy consolidation therapy in patients...
News
FDA gives nod to earlier use of Nplate in adults with ITP
The drug is now indicated for newly diagnosed and persistent adult patients with immune thrombocytopenia and an insufficient response to other...
News
Translucent particles found in Hemlibra
Genentech says the benefit-risk profile of the hemophilia A product is unchanged, and it will continue to be distributed.
News
Progressive myeloma after induction? Go straight to transplant
The study did not find a survival advantage for patients who had salvage therapy to deepen their responses before moving on to transplant.
News
Calquence earns breakthrough designation for CLL monotherapy
The Bruton tyrosine kinase inhibitor is already approved for the treatment of adults with mantle cell lymphoma who have received at least one...
News
Low-dose radiation therapy looks effective in hard-to-treat MCL
The treatment approach can be used safely with concurrent chemotherapy.
News
ABIM rolls out shorter, tailored MOC exams in oncology
The new pathway allows oncologists to choose a focused exam in hematologic malignancies, breast cancer, or general oncology every 2 years,...
Video
Cleveland Clinic targets time to treat in cancer
CHICAGO – The Taussig Cancer Institute at the Cleveland Clinic reduced the time to treat for newly diagnosed cancer patients by 33%. Taussig’s...